Skip to content

Analysis of efficacy and safety of risk adjustment based on dynamic frailty assessment in the treatment of elderly patients with multiple myeloma

Analysis of efficacy and safety of risk adjustment based on dynamic frailty assessment in the treatment of elderly patients with multiple myeloma

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078876
Enrollment
Unknown
Registered
2023-12-20
Start date
2023-12-30
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

Intermediate fit group/ Frail group:None

Sponsors

Affiliated Hospital of Hebei University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1)Age=60 years old, male or female; 2)Newly diagnosed as having MM according to the updated IMWG diagnostic criteria 2014; 3)Patients were assessed as intermediate-fit or frailty based on the IMWG-GA score,having measurable indicators,and are not eligible for autologous hematopoietic stem cell transplantation ; 4)Informed consent was obtained from the patient or the authorized principal, and informed consent was signed.

Exclusion criteria

Exclusion criteria: 1) Combined with invasive tumors that have not been effectively controlled except for multiple myeloma ; 2) Patients with known gastrointestinal diseases or surgery that could interfere with the oral absorption of drugs, gastrointestinal symptoms that cannot be controlled, including difficulty swallowing; 3) Any other medical or psychiatric condition which, in the opinion of the investigator, contraindicates the participant's participation in this study.

Design outcomes

Primary

MeasureTime frame
Objective response rate;

Secondary

MeasureTime frame
Progression free survival;Overall survival;

Countries

China

Contacts

Public ContactHua Xue

Affiliated Hospital of Hebei University

xh-xuehua@163.com+86 150 3127 3319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026